dQ&A Prescriber Perspectives
Diabetes Care Is Evolving. Is Your Strategy?
We asked 1,517 healthcare professionals in the US, EU and Canada—and conducted 24 one-hour in-depth interviews—to understand what’s changing, what isn’t, and where HCPs are heading next.
Learn more about Prescriber Perspectives 2026
The big shifts are clear:
- GLP-1s are moving earlier in the treatment journey.
- Insulin is being pushed back—even as innovation continues.
- CGM and AID still have significant room to grow, particularly in Type 2.
- HCPs are looking beyond glucose, increasingly considering weight, cardiovascular and renal risk, treatment burden and the broader needs of the patient.
Karen
Creative, Up-beat Moderator/Interviewer
"Insights I draw from our amazing panelists influence our client's smart decisions and directly improve life for very people I get to interview! How great is that?!”
Trevor
Mixed-Methods Research Expert. Multiple Published Papers.
"As someone with T1D, I'm grateful our work directly impacts devices and therapies”
Christianne
Data Services Architect. Career Research Guru.
“I have been working with dQ&A for over ten years, 100% focused on diabetes. I so love contributing to those mission-critical decisions.”
Phin
VP, Research Services. Structures big data to drive analysis and insight.
“It's a real privilege to work with data that can make such a significant difference”
Kim
10 Years on the Client Side. Delivers Actionable Insights
“At dQ&A I’m surrounded by seasoned researchers and compassionate individuals, united in our mission to make life better for people living with diabetes”
Phyllisa
Patient Advocate. Manages Content for People With Diabetes
“For the first time in my career, I don't deal with diabetes stigma in the workplace.”
Beneath the Trends
But the bigger story may be what’s happening beneath those trends. PCPs, endocrinologists and other HCPs are not moving in lockstep. They differ in:
- What they prescribe—and when they intensify
- How they weigh benefits and trade-offs
- What they believe patients will embrace or resist
- The barriers that prevent treatment and technology adoption
- How workflow, training, access and support influence what actually happens in practice
dQ&A Has Answers
For over 13 years, dQ&A has been collecting primary data from in-depth studies of diabetes healthcare practitioners (HCPs) – notably endocrinologists and primary care physicians.
Over that time, we’ve expanded our portfolio to create ‘Prescriber Perspectives’ in five countries, with input from large groups of all types of prescribers and influencers.
The insights we get are rich, representative, and actionable, and our clients use them for strategy, market intelligence, commercial decision making, influencing prescribing behavior, R&D, and marketing.
What sets us apart is our deep, hard-won experience in diabetes research, and our reputation for high-quality, reliable results. That’s why dQ&A Data Services have become the industry standard.
Do You Have Questions
About Diabetes Research?
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.
